Geron (GERN) Interest Expenses (2010 - 2026)
Geron's (GERN) quarterly Interest Expenses came in at $7.1 million in Q1 2026, down 12.84% year-on-year from $8.2 million in Q1 2025, and down 2.06% quarter-over-quarter from $7.3 million in Q4 2025.
Geron (GERN) Interest Expenses (2010 - 2026) Analysis & Trends
Geron has disclosed Interest Expenses across 17 years of filings, most recently posting $7.1 million for Q1 2026.
- Interest Expenses for Q1 2026 came in at $7.1 million, down 12.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.6 million (up 35.81% YoY), and the FY2025 annual result was $32.7 million, up 76.49% from the prior year.
- Interest Expenses came in at $7.1 million for Q1 2026 at Geron, down from $7.3 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $8.7 million in Q4 2024 to a low of $1.5 million in Q1 2022.
- The 5-year median for Interest Expenses is $3.0 million (2024), against an average of $4.3 million.
- Across the five-year window, Interest Expenses jumped 275.1% in 2024 and decreased 16.18% in 2025, its largest moves.
- Geron's Interest Expenses stood at $2.0 million in 2022, then gained by 15.76% to $2.3 million in 2023, then surged by 275.1% to $8.7 million in 2024, then fell by 16.18% to $7.3 million in 2025, then decreased by 2.06% to $7.1 million in 2026.
- The last three Interest Expenses figures came in at $7.1 million (Q1 2026), $7.3 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -5.58 Mn |
| 10 | Geron | 753,046.88 | 753,046.88 | - | 7.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.15 Mn |
| Mar 31, 2026 | 7.15 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Sep 30, 2025 | 8.64 Mn |
| Sep 30, 2025 | 8.64 Mn |
| Jun 30, 2025 | 8.52 Mn |
| Jun 30, 2025 | 8.52 Mn |
| Mar 31, 2025 | 8.20 Mn |
| Mar 31, 2025 | 8.20 Mn |
| Dec 31, 2024 | 8.71 Mn |
| Dec 31, 2024 | 8.71 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Jun 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | 3.32 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Dec 31, 2023 | 2.32 Mn |